Peptide Nanocarriers for Targeted Delivery of Nucleic Acids for Cancer Therapy

Peptides have been extensively studied in nanomedicine with great bioactivity and biocompatibility; however, their poor cell-membrane-penetrating properties and nonselectivity greatly limit their clinical applications. In this study, tumor-targeting therapy was achieved by modifying our previously developed efficient peptide vector with the cancer-targeting peptide RGD, enabling it to specifically target tumor cells with a high expression of RGD-binding receptors. B-cell lymphoma-2 antisense oligonucleotides were selected as the target model to validate the effectiveness of the delivery carriers. Results demonstrated that this delivery system can be efficiently and selectively taken up by RGD receptor-positive cells (α<sub>v</sub>β<sub>3</sub> integrin receptor), further inducing effective target gene knockdown. Overall, this system provided a promising strategy for the targeted delivery of nucleic acid drugs.

Authors

Institutions

Publication Details

Journal
Bioconjugate Chemistry
Published
2024-12-23
DOI
https://doi.org/10.1021/acs.bioconjchem.4c00324
Citations
5
Primary Topic
Advanced biosensing and bioanalysis techniques
Type
article
Field-Weighted Citation Impact
1.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Peptide Nanocarriers for Targeted Delivery of Nucleic Acids for Cancer Therapy

Leying Jiang, Dongyuan Wang, Xinrui Sha, Yaping Zhang et al.
5 citations
Bioconjugate Chemistry
Advanced biosensing and bioanalysis techniques
1.17
article

Peptide Nanocarriers for Targeted Delivery of Nucleic Acids for Cancer Therapy

Leying Jiang, Dongyuan Wang, Xinrui Sha, Yaping Zhang, Lixiang Zhang, Zijun Jiao, Xinyu Li, Xi Li, Zigang Li, Feng Yin, Zhi-Yong Yao, Chunli Song, Yun Xing
article en
5 citations

Abstract

Peptides have been extensively studied in nanomedicine with great bioactivity and biocompatibility; however, their poor cell-membrane-penetrating properties and nonselectivity greatly limit their clinical applications. In this study, tumor-targeting therapy was achieved by modifying our previously developed efficient peptide vector with the cancer-targeting peptide RGD, enabling it to specifically target tumor cells with a high expression of RGD-binding receptors. B-cell lymphoma-2 antisense oligonucleotides were selected as the target model to validate the effectiveness of the delivery carriers. Results demonstrated that this delivery system can be efficiently and selectively taken up by RGD receptor-positive cells (α<sub>v</sub>β<sub>3</sub> integrin receptor), further inducing effective target gene knockdown. Overall, this system provided a promising strategy for the targeted delivery of nucleic acid drugs.

Bioconjugate ChemistryVol. 36(1)
Union Hospital (HK), Peking University (CN), Shenzhen Bay Laboratory (CN), Huazhong University of Science and Technology (CN)
Science and Technology Foundation of Shenzhen City, Natural Science Foundation of Guangdong Province, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen Bay Laboratory, National Key Research and Development Program of China, Beijing National Laboratory for Molecular Sciences
Good health and well-being
Openalex Percentile: Top 21%
Advanced biosensing and bioanalysis techniques
1.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.